Literature DB >> 3677784

Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.

J P Gilbard1, L A Hanninen, R C Rothman, K R Kenyon.   

Abstract

The NZB/NZW F1 hybrid mouse has been reported to contract a disease similar to Sjögren's syndrome in man. We studied lacrimal gland morphology, corneal morphology, and tear osmolarity in this mouse as a function of age. Lacrimal glands of hybrid mice contained abnormal periductal infiltrates of lymphocytes and plasma cells. Maximum infiltration of the lacrimal gland occurred in the 29-week-old female hybrid mouse and was estimated to involve 12% of the gland, but was insufficient to alter tear osmolarity relative to DBA and Balb/c control mice. Nevertheless, both NZB/NZW F1 hybrid mice and DBA and Balb/c control mice had tear osmolarity and corneal surface morphology similar to that reported for keratoconjunctivitis sicca in man. Although the NZB/NZW F1 hybrid mouse may provide a valuable model for the study of lacrimal gland infiltration, since its tear osmolarity and ocular surface remain normal for a mouse, its usefulness as a model for ocular surface disease in human keratoconjunctivitis sicca may be more limited than previously thought.

Entities:  

Mesh:

Year:  1987        PMID: 3677784     DOI: 10.3109/02713688709025234

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  3 in total

Review 1.  The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Authors:  Harini Bagavant; Aleksandra Michrowska; Umesh S Deshmukh
Journal:  Autoimmun Rev       Date:  2020-10-22       Impact factor: 9.754

2.  Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.

Authors:  Máire E Doyle; Lori Boggs; Robert Attia; Lauren R Cooper; Daniel R Saban; Cuong Q Nguyen; Ammon B Peck
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 3.  Sjögren syndrome: what and where are we looking for?

Authors:  Cintia S de Paiva; Eduardo Melani Rocha
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.